LMR Partners’s Biolase, Inc. BIOL Stock Holding History

LMR Partners’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-6	Closed	-$164K	–	498
2014 Q2	$164K	Buy	+6	New	+$153K	0.01%	417

Other funds holding BIOL

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LMR Partners's BIOL Position: Q3 2014 in Review

LMR Partners sold out of Biolase, Inc. (BIOL) in Q3 2014, closing a stake of 6 shares — an estimated $164K sold.

LMR Partners first reported a position in BIOL in Q2 2014 and held it in 1 quarter. The position peaked at $164K in Q2 2014. 35 funds tracked by Wall St. Rank hold BIOL as of Q3 2014.

LMR Partners reported no remaining Biolase, Inc. position as of Q3 2014 after selling out during the quarter.
LMR Partners sold 6 Biolase, Inc. shares in Q3 2014, an estimated $164K.
LMR Partners first reported a position in Biolase, Inc. in Q2 2014 and held it in 1 quarter.
LMR Partners's Biolase, Inc. position peaked at $164K in Q2 2014.
35 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2014.

Based on LMR Partners's 13F filing for Q3 2014, filed 20 Oct 2014.